You have read all your free articles, to continue reading subscribe to read the rest of this content.
Pfizer and BioNTech have had concluded exploratory talks with the European Commission for a proposed supply of 200 million doses of their investigational BNT162 mRNA-based vaccine candidate against SARS-CoV-2 to European Union (EU) Member States, with an option for further 100 million doses. DeliAlready a subscriber Login You have read…
AstraZeneca’s COVID-19 vaccine has been granted a special approval for emergency use in Japan for active immunization of individuals aged 18 years and older, to prevent COVID-19 caused by SARS-CoV-2. The Japanese Ministry of Health, Labour and Welfare granted the approval based on positive PhasAlready a subscriber Login You have…
BerGenBio has announced that bemcentinib has been selected as the first potential treatment to be fast-tracked in a new UK national multi-centre randomized Phase II clinical trial initiative. The ACcelerating COVID-19 Research & Development platform (ACCORD) study is being funded by the DeparAlready a subscriber Login You have read all…
An international research consortium has developed a ‘double antibody’ that targets two different sites of the SARS-CoV-2 virus, thereby preventing the virus from mutating to resist the therapy. The research consortium, including researchers at Karolinska Institutet, show that the antibody poAlready a subscriber Login You have read all your free…
